(e,e,e,e)-squalene

(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (e,e,e,e)-squalene?

(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Occupational D009783 12 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 100 | Total 84

PubChem Associated disorders and diseases

What pathways are associated with (e,e,e,e)-squalene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (e,e,e,e)-squalene?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (e,e,e,e)-squalene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (e,e,e,e)-squalene

Download all related citations
Per page 10 20 50 100 | Total 1766
Authors Title Published Journal PubMed Link
Lepeltier E et al. Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles. 2013 Langmuir pmid:24219056
Ambike A et al. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. 2011 Langmuir pmid:21413743
McElhaney JE et al. AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. 2013 Lancet Infect Dis pmid:23518156
Ledgerwood JE AS03-adjuvanted influenza vaccine in elderly people. 2013 Lancet Infect Dis pmid:23518157
Budiarso IT Fish oil versus olive oil. 1990 Lancet pmid:1978131
Rickman LS et al. Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. 1991 Lancet pmid:1673211
Nicholson KG et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. 2001 Lancet pmid:11425416
Griffiths PD et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. 2011 Lancet pmid:21481708
Houston L et al. Response of guinea pigs to a vaccine containing a new adjuvant (SAF) and gram-negative bacteria. 1995 Lab. Anim. Sci. pmid:7752616
Robuccio JA et al. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs. 1995 Lab. Anim. Sci. pmid:7474883
Murakami S Isolation and analysis of squalene alcohols from rat preputial glands. 1973 Kobe J Med Sci pmid:4764042
SCHOEN H and FAHSOLD W [Studies on the problem of resorption of squalene]. 1960 Klin. Wochenschr. pmid:14443328
Suzuki R Specific requirements of bile salts for absorption of cholesterol from the intestine. 1968 Keio J Med pmid:5715537
Hwang SM et al. Comparison of the adverse events associated with MF59-adjuvanted and non-adjuvanted H1N1 vaccines in healthy young male Korean soldiers. 2012 Jpn. J. Infect. Dis. pmid:22627298
Nakagawa M et al. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. 1985 Jpn. J. Cancer Res. pmid:2408954
Yamaguchi T et al. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system. 1985 Jpn. J. Cancer Res. pmid:3935620
Tabache F et al. Acute polyarthritis after influenza A (H1N1) immunization. 2011 Joint Bone Spine pmid:21444232
Treanor JJ Expanding the options for confronting pandemic influenza. 2014 JAMA pmid:25291574
Belshe RB et al. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial. 2014 JAMA pmid:25291578
Mulligan MJ et al. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial. 2014 JAMA pmid:25291577
Stoskopf MK et al. The impact of water temperature on core body temperature of North American river otters (Lutra canadensis) during simulated oil spill recovery washing protocols. 1997 J. Zoo Wildl. Med. pmid:9523634
van den Brand JM et al. Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets. 2011 J. Virol. pmid:21209108
Chmielewska AM et al. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. 2014 J. Virol. pmid:24599994
Stephenson I et al. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. 2006 J. Virol. pmid:16641287
Lin Y et al. Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5. 2008 J. Virol. pmid:18508900
Barnett SW et al. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. 2010 J. Virol. pmid:20392857
Nesburn AB et al. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits. 1998 J. Virol. pmid:9733807
Verschoor EJ et al. Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance. 1999 J. Virol. pmid:10074183
Soloway AH and LeQuesne PW Potential endogenous mutagens/carcinogens. 1980 J. Theor. Biol. pmid:7464159
van Leusden HA et al. Lack of squalene and lanosterol synthesis by the perfused human placenta at term. 1973 J. Steroid Biochem. pmid:4747979
Caspi E et al. Mechanism of squalene cyclization: the chiral origin of the C-7 and C-15 hydrogen atoms of fusidic acid. 1973 J. Steroid Biochem. pmid:4795867
Bird S and Gower DB Axillary 5 alpha-androst-16-en-3-one, cholesterol and squalene in men; preliminary evidence for 5 alpha-androst-16-en-3-one being a product of bacterial action. 1982 J. Steroid Biochem. pmid:7176644
Gutfinger T and Letan A Quantitative changes in some unsaponifiable components of soya bean oil due to refining. 1974 J. Sci. Food Agric. pmid:4473685
Garrett IR et al. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats. 1985 J. Rheumatol. pmid:3937896
Deng X et al. Immunological response of female macaques to the PH-20 sperm protein following injection of recombinant proteins or synthesized peptides. 2002 J. Reprod. Immunol. pmid:11839398
Conner RL et al. Cholesterol inhibition of pentacyclic triterpenoid biosynthesis in Tetrahymena pyriformis. 1968 J. Protozool. pmid:5703082
Copado MA et al. Fatty acids and squalene carried by alpha fetoprotein, and fetal and adult serum albumin from chicken. Comparison with these from mammals. 1999 J. Protein Chem. pmid:10449039
Ruiz-Gutiérrez V et al. Detection of squalene in alpha-fetoprotein and fetal serum albumin from bovine. 2001 J. Protein Chem. pmid:11330344
MACKENNA RM et al. Squalene and other hydrocarbons in human sebum. 1955 J. Physiol. (Lond.) pmid:14354699
Reddy LH et al. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. 2008 J. Pharmacol. Exp. Ther. pmid:18258784
Kamimura H et al. Enhanced elimination of theophylline, phenobarbital and strychnine from the bodies of rats and mice by squalane treatment. 1992 J. Pharmacobio-dyn. pmid:1527697
Ohkuma T et al. Intensification of host's immunity by squalene in sarcoma 180 bearing ICR mice. 1983 J. Pharmacobio-dyn. pmid:6864440
O'Hagan DT Recent advances in vaccine adjuvants for systemic and mucosal administration. 1998 J. Pharm. Pharmacol. pmid:9504429
Rabiskova M et al. The influence of surface properties on uptake of oil into complex coacervate microcapsules. 1994 J. Pharm. Pharmacol. pmid:7815274
Sajbidor J et al. Influence of new fenpropimorph fungicides on the growth and sterol composition in Saccharomyces cerevisiae: relationship between structure and activity. 1998 J. Pharm. Pharmacol. pmid:9600722
Xiong Q et al. Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis. 2005 J. Org. Chem. pmid:15989315
Barrero AF et al. Solid-phase selenium-catalyzed selective allylic chlorination of polyprenoids: facile syntheses of biologically active terpenoids. 2006 J. Org. Chem. pmid:16839173
Tong R et al. Stereo- and regioselective synthesis of squalene tetraepoxide. 2009 J. Org. Chem. pmid:19827774
Koohang A et al. Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate. 2010 J. Org. Chem. pmid:20545375
Fontana A et al. Evidence for the biosynthesis of squalene via the methylerythritol phosphate pathway in a Streptomyces sp. obtained from a marine sediment. 2001 J. Org. Chem. pmid:11529755
Barrero AF et al. Mild TiIII- and Mn/ZrIV-catalytic reductive coupling of allylic halides: efficient synthesis of symmetric terpenes. 2007 J. Org. Chem. pmid:17375959
Someya K et al. The antioxidant effect of palm fruit carotene on skin lipid peroxidation in guinea pigs as estimated by chemiluminescence-HPLC method. 1994 J. Nutr. Sci. Vitaminol. pmid:7844638
Singh DK and Porter TD Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. 2006 J. Nutr. pmid:16484558
HIGH EG and DAY HG Effects of different amounts of lutein, squalene, phytol and related substances on the utilization of carotene and vitamin A for storage and growth in the rat. 1951 J. Nutr. pmid:14851042
Matschiner JT et al. Effect of indigestible oils on vitamin K deficiency in the rat. 1967 J. Nutr. pmid:6021812
Matschiner JT et al. Mechanism of the effect of retinoic acid and squalene on vitamin K deficiency in the rat. 1967 J. Nutr. pmid:6021953
Shao MJ and Lei KY Conversion of [2-14C] mevalonate into cholesterol, lanosterol and squalene in copper-deficient rats. 1980 J. Nutr. pmid:7373433
Michikawa M and Yanagisawa K Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. 1998 J. Neurosci. Res. pmid:9778150
Schulz JG et al. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. 2004 J. Neurochem. pmid:15030386
Jones JP et al. Rate of sterol formation by rat brain glia and neurons in vitro and in vivo. 1975 J. Neurochem. pmid:1110355
Wagner-Recio M et al. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination. 1991 J. Neurochem. pmid:1940905
Harry GJ et al. Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve. 1989 J. Neurochem. pmid:2918316
Dennick RG et al. Sterol content and squaline-2(3)-epoxide-lanosterol cyclase activity in human foetal brain during early and mid-gestation. 1974 J. Neurochem. pmid:4854410
Ramsey RB et al. The biosynthesis of cholesterol and other sterols by brain tissue. Distribution in subcellular fractions as a function of time after intracerebral injection into developing brain of (2- 14 C)mevalonic. 1972 J. Neurochem. pmid:5009889
Ramsey RB et al. Squalene-like isoprenoid hydrocarbons in bovine brain. 1971 J. Neurochem. pmid:5129357
Ramsey RB et al. The biosynthesis of cholesterol and other sterols by brain tissue. Distribution in subcellular fractions as a function of time after intracerebral injection of [2-14C]-mevalonic acid. 1971 J. Neurochem. pmid:5092868
Michikawa M and Yanagisawa K Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. 1999 J. Neurochem. pmid:10349836
Dennick RG and Dean PD Squalene-2(3)-epoxide-lanosterol cyclase in developing rat brain. 1974 J. Neurochem. pmid:4277662
Shamberger RJ Inhibitory effect of vitamin A on carcinogenesis. 1971 J. Natl. Cancer Inst. pmid:5157584
Harro CD et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. 2001 J. Natl. Cancer Inst. pmid:11181775
Asari F et al. Turbinaric acid, a cytotoxic secosqualene carboxylic acid from the brown alga Turbinaria ornata. 1989 Sep-Oct J. Nat. Prod. pmid:2607351
Tran TV et al. NF-κB inhibitors from Eurycoma longifolia. 2014 J. Nat. Prod. pmid:24467387
Noro JC et al. Tetrahdroxysqualene from Rhus taitensis shows antimycobacterial activity against Mycobacterium tuberculosis. 2008 J. Nat. Prod. pmid:18710283
Abe I et al. Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase. 2001 J. Nat. Prod. pmid:11520216
Gaber BP and Goodsell DS The art of molecular graphics. Escape from flatland. 2000 J. Mol. Graph. Model. pmid:10935209
Tornabene TG Non-aerated cultivation of Halobacterium cutirubrum and its effect on cellular squalenes. 1978 J. Mol. Evol. pmid:691076
Tornabene TG et al. Phytanyl-glycerol ethers and squalenes in the archaebacterium Methanobacterium thermoautotrophicum. 1978 J. Mol. Evol. pmid:691077
Tornabene TG et al. Squalenes, phytanes and other isoprenoids as major neutral lipids of methanogenic and thermoacidophilic "archaebacteria". 1979 J. Mol. Evol. pmid:458874
Peri A and Serio M Neuroprotective effects of the Alzheimer's disease-related gene seladin-1. 2008 J. Mol. Endocrinol. pmid:18768664
Hong WK et al. Characterization of a squalene synthase from the thraustochytrid microalga Aurantiochytrium sp. KRS101. 2013 J. Microbiol. Biotechnol. pmid:23676912
Song JY et al. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine. 2013 J. Med. Virol. pmid:23852684
Morita T et al. Inhibitory effect of a new mycotic agent, piritetrate on ergosterol biosynthesis in pathogenic fungi. 1989 J. Med. Vet. Mycol. pmid:2666631
Barrett-Bee KJ et al. The mode of antifungal action of tolnaftate. 1986 J. Med. Vet. Mycol. pmid:3522841
Yoder JA et al. Squalene: a naturally abundant mammalian skin secretion and long distance tick-attractant (Acari: Ixodidae). 1999 J. Med. Entomol. pmid:10467784
Raouane M et al. Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. 2011 J. Med. Chem. pmid:21561161
Sen SE et al. Inhibition of vertebrate squalene epoxidase by extended and truncated analogues of trisnorsqualene alcohol. 1990 J. Med. Chem. pmid:2342064
Sen SE and Prestwich GD Squalene analogues containing isopropylidene mimics as potential inhibitors of pig liver squalene epoxidase and oxidosqualene cyclase. 1989 J. Med. Chem. pmid:2769687
Ceruti M et al. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 1998 J. Med. Chem. pmid:9484504
Stach D et al. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase. 1997 J. Med. Chem. pmid:9003518
Chan C et al. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. 1996 J. Med. Chem. pmid:8568810
Barth MM et al. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives. 1996 J. Med. Chem. pmid:8691425
Prashad M Amidinium cation as a mimic of allylic carbocation: synthesis and squalene synthetase inhibitory activity of an amidinium analog of a carbocation intermediate. 1993 J. Med. Chem. pmid:8496942
Ceruti M et al. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 1992 J. Med. Chem. pmid:1501233
Witiak DT et al. Inhibition of cholesterolgenesis in vitro by chlorophenoxyacetic acids. Effect of alpha-methyl groups. 1969 J. Med. Chem. pmid:5793168
Strandberg TE et al. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. 1990 J. Lipid Res. pmid:2246614
Liu GC et al. Measurement of squalene in human tissues and plasma: validation and application. 1976 J. Lipid Res. pmid:1255019
Eisele B et al. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo. 1997 J. Lipid Res. pmid:9101437
Gylling H et al. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. 2010 J. Lipid Res. pmid:20436182
Raskin P and Siperstein MD Mevalonate metabolism by renal tissue in vitro. 1974 J. Lipid Res. pmid:4811213
Shechter I et al. A deficiency of mixed function oxidase activities in the cholesterol biosynthetic pathway of human granulocytes. 1980 J. Lipid Res. pmid:7381322